Shop

Showing 209–224 of 1289 results

• 

  Article: Clinical management of first-line advanced triple-negative breast cancer patients

  €3.03 Add to cart
• 

  Article: Clinical outcome and prognostic factors in oligometastatic breast cancer

  €3.03 Add to cart
• 

  Article: Clinical practice guidelines for the treatment of rectal cancer patients: The Leuven Rectal Cancer Consensus

  €3.03 Add to cart
• 

  Article: Clinical presentation, natural history and therapeutic approach in patients with solitary fibrous tumor: a retrospective analysis

  €3.03 Add to cart
• 

  Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

  €3.03 Add to cart
• 

  Article: Co-inhibition of BRAF and MEK signalling delays progression in BRAF-mutant metastatic melanoma

  €3.03 Add to cart
• 

  Article: Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer

  €3.03 Add to cart
• 

  Article: Combined PD-1 and CTLA4 inhibition delays progression in advanced melanoma

  €3.03 Add to cart
• 

  Article: Combining EGFR-TKIs and chemotherapy in patients with advanced non-small cell lung cancer: time for a new standard of care?

  €3.03 Add to cart
• 

  Article: Combining local ablative therapy with immunotherapy

  €3.03 Add to cart
• 

  Article: Comment on a previously published practice guidelines article

  €3.03 Add to cart
• 

  Article: Concerning a previously published Introduction

  €3.03 Add to cart
• 

  Article: Concerning a previously published practice guidelines article

  €3.03 Add to cart
• 

  Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7

  €3.03 Add to cart
• 

  Article: Confirmed survival benefit of combined BRAF and MEK inhibition in advanced BRAF mutant melanoma

  €3.03 Add to cart
• 

  Article: Congress Calendar

  €3.03 Add to cart